Tricyclic antidepressants: An update
DOI:
https://doi.org/10.33448/rsd-v13i4.45539Keywords:
Tricyclic antidepressive agents; Mental disorders; Psychotropic drugs; Therapeutic uses; Drug-related side effects and adverse reactions.Abstract
Tricyclic antidepressants (TCAs) are a class of psychotropic medications primarily used in the treatment of major depressive disorders, although their indications extend to a variety of psychiatric and neurological conditions. This class of medications was one of the first to be developed for the treatment of depression, marking a revolution in the management of this condition in the mid-20th century. The aim of this study is to present a narrative review in the form of an update on the pharmacokinetic properties, pharmacodynamics, indications, and side effects of tricyclic antidepressants. For this purpose, a narrative review in the format of an update was carried out, which analyzed 42 manuscripts. TCAs have various pharmacological and therapeutic properties, low cost, but their major limitation is their side effects. Since the clinical trials for this class were conducted well before the launch of new antidepressants, new research is needed to allow comparison of these groups within the same methodology and with more up-to-date statistics.
References
Aigner, M., Treasure, J., Kaye, W., Kasper, S., & Disorders, W. T. F. O. E. (2011). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. World J Biol Psychiatry, 12 (6), 400-443. https://doi.org/10.3109/15622975.2011.602720
Arroll, B., Macgillivray, S., Ogston, S., Reid, I., Sullivan, F., Williams, B., & Crombie, I. (2005). Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Ann Fam Med, 3 (5), 449-456. https://doi.org/10.1370/afm.349
Bakker, A., van Balkom, A. J., & Spinhoven, P. (2002). SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis. Acta Psychiatr Scand, 106 (3), 163-167. https://doi.org/10.1034/j.1600-0447.2002.02255.x
Baldaçara, L. (2021). Emergências Psiquiátricas. In A. G. da Silva, A. E. Nardi, & A. P. Diaz (Eds.), Programa de Educação Continuada em Psiquiatria (PEC-ABP). Temas fundamentais (1 ed., pp. 267-282). Artmed.
Baldaçara, L., Cordeiro, D. C., Calfat, E. L. B., Cordeiro, D. C., & Chung, T. C. (2019). Emergências Psiquiátricas (2, Ed.). Elsevier.
Baldaçara, L., & da Silva, A. G. (2021). Suporte em Emergências Psiquiátricas (SEP) (1 ed.). AMPLA.
Baldaçara, L., Grudtner, R. R., Leite, V. S., Porto, D. M., Robis, K. P., Fidalgo, T. M., Rocha, G. A., Díaz, A. P., Meleiro, A., Correa, H., Tung, T. C., Malloy-Diniz, L. F., & da Silva, A. G. (2021). Brazilian guidelines for the management of suicide behavior. Part 2. Screening, intervention, and prevention. Braz J Psychiatry, Forthcoming 2020.
Baldaçara, L., Pettersen, A. G., Leite, V. D. S., Ismael, F., Motta, C. P., Freitas, R. A., Fasanella, N. A., Pereira, L. A., Barros, M. E. L., Barbosa, L., Teles, A. L. S., Palhano, R., Guimaraes, H. P., Braga, M. A., Castaldelli-Maia, J. M., Bicca, C., Gligliotti, A., Marques, A., & da Silva, A. G. (2022). Brazilian Psychiatric Association Consensus for the Management of Acute Intoxication. General management and specific interventions for drugs of abuse. Trends Psychiatry Psychother. https://doi.org/10.47626/2237-6089-2022-0571
Baldaçara, L., Rocha, G. A., Leite, V. D. S., Porto, D. M., Grudtner, R. R., Diaz, A. P., Meleiro, A., Correa, H., Tung, T. C., Quevedo, J., & da Silva, A. G. (2021). Brazilian Psychiatric Association guidelines for the management of suicidal behavior. Part 1. Risk factors, protective factors, and assessment. Braz J Psychiatry. https://doi.org/10.1590/1516-4446-2020-0994
Baldaçara, L., & Tung, T. C. (2020). Condutas em psiquiatria. Manole.
Baldaçara, L., Weber, C. A. T., Gorender, M., Grudtner, R. R., Peu, S., Teles, A. L. S., Cavalcante, I. P., Quevedo, J., & da Silva, A. G. (2022). Brazilian Psychiatric Association guidelines for the management of suicidal behavior. Part 3. Suicide prevention hotlines. Braz J Psychiatry. https://doi.org/10.47626/1516-4446-2022-2536
Bandelow, B. (2008). The medical treatment of obsessive-compulsive disorder and anxiety. CNS Spectr, 13 (9 Suppl 14), 37-46. https://doi.org/10.1017/s1092852900026924
Bandelow, B., Reitt, M., Rover, C., Michaelis, S., Gorlich, Y., & Wedekind, D. (2015). Efficacy of treatments for anxiety disorders: a meta-analysis. Int Clin Psychopharmacol, 30 (4), 183-192. https://doi.org/10.1097/YIC.0000000000000078
Barbara, G., Cremon, C., Bellini, M., Corsetti, M., Di Nardo, G., Falangone, F., Fuccio, L., Galeazzi, F., Iovino, P., Sarnelli, G., Savarino, E. V., Stanghellini, V., Staiano, A., Stasi, C., Tosetti, C., Turco, R., Ubaldi, E., Zagari, R. M., Zenzeri, L., & Marasco, G. (2023). Italian guidelines for the management of irritable bowel syndrome: Joint Consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), General Medicine (SIMG), Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP) and Pediatrics (SIP). Dig Liver Dis, 55 (2), 187-207. https://doi.org/10.1016/j.dld.2022.11.015
Bezerra, T. P. T., Fabrício, A. I. C. R., Minervino, A. J., & Santos, R. M. d. (2023). Psychoactive drugs and metabolic disorders. Debates em Psiquiatria, 13, 1-20. https://doi.org/10.25118/2763-9037.2023.v13.439
Brasil. (2024). Listas de preços de medicamentos. Ministério da Saúde - ANVISA. https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/cmed/precos
Caldwell, P. H., Sureshkumar, P., & Wong, W. C. (2016). Tricyclic and related drugs for nocturnal enuresis in children. Cochrane Database Syst Rev, 2016 (1), CD002117. https://doi.org/10.1002/14651858.CD002117.pub2
Calvi, A., Fischetti, I., Verzicco, I., Belvederi Murri, M., Zanetidou, S., Volpi, R., Coghi, P., Tedeschi, S., Amore, M., & Cabassi, A. (2021). Antidepressant Drugs Effects on Blood Pressure. Frontiers in Cardiovascular Medicine, 8. https://doi.org/10.3389/fcvm.2021.704281
Chan, H. N., Fam, J., & Ng, B. Y. (2009). Use of antidepressants in the treatment of chronic pain. Ann Acad Med Singap, 38 (11), 974-979. https://www.ncbi.nlm.nih.gov/pubmed/19956820
Chang, L., Sultan, S., Lembo, A., Verne, G. N., Smalley, W., & Heidelbaugh, J. J. (2022). AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation. Gastroenterology, 163 (1), 118-136. https://doi.org/10.1053/j.gastro.2022.04.016
Chinn, S., Caldwell, W., & Gritsenko, K. (2016). Fibromyalgia Pathogenesis and Treatment Options Update. Curr Pain Headache Rep, 20 (4), 25. https://doi.org/10.1007/s11916-016-0556-x
Everitt, H., Baldwin, D. S., Stuart, B., Lipinska, G., Mayers, A., Malizia, A. L., Manson, C. C., & Wilson, S. (2018). Antidepressants for insomnia in adults. Cochrane Database Syst Rev, 5 (5), CD010753. https://doi.org/10.1002/14651858.CD010753.pub2
Gillman, P. K. (2007). Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. Br J Pharmacol, 151 (6), 737-748. https://doi.org/10.1038/sj.bjp.0707253
Guaiana, G., Meader, N., Barbui, C., Davies, S. J., Furukawa, T. A., Imai, H., Dias, S., Caldwell, D. M., Koesters, M., Tajika, A., Bighelli, I., Pompoli, A., Cipriani, A., Dawson, S., & Robertson, L. (2023). Pharmacological treatments in panic disorder in adults: a network meta-analysis. Cochrane Database Syst Rev, 11 (11), CD012729. https://doi.org/10.1002/14651858.CD012729.pub3
Kerr, G. W. (2001). Tricyclic antidepressant overdose: a review. Emergency Medicine Journal, 18 (4), 236-241. https://doi.org/10.1136/emj.18.4.236
Lenze, E. J., Mulsant, B. H., Roose, S. P., Lavretsky, H., Reynolds, C. F., Blumberger, D. M., Brown, P. J., Cristancho, P., Flint, A. J., Gebara, M. A., Gettinger, T. R., Lenard, E., Miller, J. P., Nicol, G. E., Oughli, H. A., Pham, V. T., Rollman, B. L., Yang, L., & Karp, J. F. (2023). Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression. New England Journal of Medicine, 388 (12), 1067-1079. https://doi.org/10.1056/NEJMoa2204462
Marazziti, D., Albert, U., Dell'Osso, B., Tundo, A., Cuniberti, F., Maina, G., Moroni, I., Benatti, B., Mucci, F., Massimetti, G., Piccinni, A., & Brakoulias, V. (2017). Italian prescribing patterns in obsessive-compulsive disorder. Hum Psychopharmacol, 32 (6). https://doi.org/10.1002/hup.2641
Moraczewski, J., Awosika, A. O., & Aedma, K. K. (2024). Tricyclic Antidepressants. StatPearls.
Moraczewski, J., Awosika, A. O., & Aedma, K. K. (2024). Tricyclic Antidepressants. In StatPearls. https://www.ncbi.nlm.nih.gov/pubmed/32491723
Nascimento, C. d. P., Couto, H. Z., Baldaçara, L., Silva, A. G. d., Mello, M. F. d., & Mello, A. F. d. (2023). Pharmacological treatment of post-traumatic stress disorder: a treatment guide based on a systematic literature review. Debates em Psiquiatria, 13, 1-72. https://doi.org/10.25118/2763-9037.2023.v13.1037
Ogawa, Y., Takeshima, N., Hayasaka, Y., Tajika, A., Watanabe, N., Streiner, D., & Furukawa, T. A. (2019). Antidepressants plus benzodiazepines for adults with major depression. Cochrane Database Syst Rev, 6 (6), CD001026. https://doi.org/10.1002/14651858.CD001026.pub2
Özkaya, E., Babuna Kobaner, G., Yılmaz, Z., & Kutlay, A. (2019). Doxepin in difficult‐to‐treat chronic urticaria: A retrospective, cross‐sectional study from Turkey. Dermatologic Therapy. https://doi.org/10.1111/dth.12993
Royal, A., New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Panic, D., & Agoraphobia. (2003). Australian and New Zealand clinical practice guidelines for the treatment of panic disorder and agoraphobia. Aust N Z J Psychiatry, 37 (6), 641-656. https://doi.org/10.1080/j.1440-1614.2003.01254.x
Saarto, T., & Wiffen, P. J. (2007). Antidepressants for neuropathic pain. Cochrane Database Syst Rev, 2007 (4), CD005454. https://doi.org/10.1002/14651858.CD005454.pub2
Schneider, J., Patterson, M., & Jimenez, X. F. (2019). Beyond depression: Other uses for tricyclic antidepressants. Cleve Clin J Med, 86 (12), 807-814. https://doi.org/10.3949/ccjm.86a.19005
Shaha, D. (2023). Insomnia Management: A Review and Update. J Fam Pract, 72 (06 Supp). https://doi.org/10.12788/jfp.0620
Skaer, T. L. (2014). Fibromyalgia: disease synopsis, medication cost effectiveness and economic burden. Pharmacoeconomics, 32 (5), 457-466. https://doi.org/10.1007/s40273-014-0137-y
Snyder, H. (2019). Literature review as a research methodology: An overview and guidelines. Journal of Business Research, 104, 333-339. https://doi.org/10.1016/j.jbusres.2019.07.039
Thouaye, M., & Yalcin, I. (2023). Neuropathic pain: From actual pharmacological treatments to new therapeutic horizons. Pharmacol Ther, 251, 108546. https://doi.org/10.1016/j.pharmthera.2023.108546
Ulrich, S., Ricken, R., Buspavanich, P., Schlattmann, P., & Adli, M. (2020). Efficacy and Adverse Effects of Tranylcypromine and Tricyclic Antidepressants in the Treatment of Depression: A Systematic Review and Comprehensive Meta-analysis. J Clin Psychopharmacol, 40 (1), 63-74. https://doi.org/10.1097/JCP.0000000000001153
Undurraga, J., & Baldessarini, R. J. (2017). Direct comparison of tricyclic and serotonin-reuptake inhibitor antidepressants in randomized head-to-head trials in acute major depression: Systematic review and meta-analysis. J Psychopharmacol, 31 (9), 1184-1189. https://doi.org/10.1177/0269881117711709
Zohar, J., & Westenberg, H. G. (2000). Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand 403, 39-49. https://doi.org/10.1111/j.1600-0447.2000.tb10947.x
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Leonardo Baldaçara; Railson Freitas; Raquel Prudente de Carvalho Baldaçara
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
